Cargando…
Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity
Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pande...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246442/ https://www.ncbi.nlm.nih.gov/pubmed/34226815 http://dx.doi.org/10.1007/s11831-021-09613-7 |
_version_ | 1783716312617320448 |
---|---|
author | Wedel, Jana Steinmann, Paul Štrakl, Mitja Hriberšek, Matjaž Ravnik, Jure |
author_facet | Wedel, Jana Steinmann, Paul Štrakl, Mitja Hriberšek, Matjaž Ravnik, Jure |
author_sort | Wedel, Jana |
collection | PubMed |
description | Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the human airways is used and particle transport under various levels of cardiovascular activity in enclosed spaces is studied by means of computational fluid dynamics. The influence of the room size, where the activity takes place, and the aerosol concentration is studied. The contribution aims to assess the risk of various levels of exercising while inhaling infectious pathogens to gain further insights in the deposition behavior of aerosols in the human airways. The size distribution of the expiratory droplets or aerosols plays a crucial role for the disease onset and progression. As the size of the expiratory droplets and aerosols differs for various exhaling scenarios, reported experimental particle size distributions are taken into account when setting up the environmental conditions. To model the aerosol deposition we employ [Formula: see text] by using an Euler-Lagrangian frame including Reynolds-Averaged Navier–Stokes resolved turbulent flow. Within this study, the effects of different exercise levels and thus breathing rates as well as particle size distributions and room sizes are investigated to enable new insights into the local particle deposition in the human airway and virus loads. A general observation can be made that exercising at higher levels of activity is increasing the risk to develop a severe cause of the COVID-19 disease due to the increased aerosolized volume that reaches into the lower airways, thus the knowledge of the inhaled particle dynamics in the human airways at various exercising levels provides valuable information for infection control strategies. |
format | Online Article Text |
id | pubmed-8246442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-82464422021-07-01 Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity Wedel, Jana Steinmann, Paul Štrakl, Mitja Hriberšek, Matjaž Ravnik, Jure Arch Comput Methods Eng S.I.: Modeling and Simulation of Infectious Diseases Since end of 2019 the COVID-19 pandemic, caused by the SARS-CoV-2 virus, is threatening humanity. Despite the fact that various scientists across the globe try to shed a light on this new respiratory disease, it is not yet fully understood. Unlike many studies on the geographical spread of the pandemic, including the study of external transmission routes, this work focuses on droplet and aerosol transport and their deposition inside the human airways. For this purpose, a digital replica of the human airways is used and particle transport under various levels of cardiovascular activity in enclosed spaces is studied by means of computational fluid dynamics. The influence of the room size, where the activity takes place, and the aerosol concentration is studied. The contribution aims to assess the risk of various levels of exercising while inhaling infectious pathogens to gain further insights in the deposition behavior of aerosols in the human airways. The size distribution of the expiratory droplets or aerosols plays a crucial role for the disease onset and progression. As the size of the expiratory droplets and aerosols differs for various exhaling scenarios, reported experimental particle size distributions are taken into account when setting up the environmental conditions. To model the aerosol deposition we employ [Formula: see text] by using an Euler-Lagrangian frame including Reynolds-Averaged Navier–Stokes resolved turbulent flow. Within this study, the effects of different exercise levels and thus breathing rates as well as particle size distributions and room sizes are investigated to enable new insights into the local particle deposition in the human airway and virus loads. A general observation can be made that exercising at higher levels of activity is increasing the risk to develop a severe cause of the COVID-19 disease due to the increased aerosolized volume that reaches into the lower airways, thus the knowledge of the inhaled particle dynamics in the human airways at various exercising levels provides valuable information for infection control strategies. Springer Netherlands 2021-07-01 2021 /pmc/articles/PMC8246442/ /pubmed/34226815 http://dx.doi.org/10.1007/s11831-021-09613-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | S.I.: Modeling and Simulation of Infectious Diseases Wedel, Jana Steinmann, Paul Štrakl, Mitja Hriberšek, Matjaž Ravnik, Jure Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title | Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title_full | Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title_fullStr | Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title_full_unstemmed | Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title_short | Risk Assessment of Infection by Airborne Droplets and Aerosols at Different Levels of Cardiovascular Activity |
title_sort | risk assessment of infection by airborne droplets and aerosols at different levels of cardiovascular activity |
topic | S.I.: Modeling and Simulation of Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246442/ https://www.ncbi.nlm.nih.gov/pubmed/34226815 http://dx.doi.org/10.1007/s11831-021-09613-7 |
work_keys_str_mv | AT wedeljana riskassessmentofinfectionbyairbornedropletsandaerosolsatdifferentlevelsofcardiovascularactivity AT steinmannpaul riskassessmentofinfectionbyairbornedropletsandaerosolsatdifferentlevelsofcardiovascularactivity AT straklmitja riskassessmentofinfectionbyairbornedropletsandaerosolsatdifferentlevelsofcardiovascularactivity AT hribersekmatjaz riskassessmentofinfectionbyairbornedropletsandaerosolsatdifferentlevelsofcardiovascularactivity AT ravnikjure riskassessmentofinfectionbyairbornedropletsandaerosolsatdifferentlevelsofcardiovascularactivity |